Documentation Dilemma, Part 2: Why Can’t I Just Use AI on Its Own?

AI is transforming the pharmaceutical industry at a clipping rate. Yet, AI on its own just isn’t enough for documentation. A structured content management solution — designed specifically for life sciences — is the key to creating the guardrails necessary for the industry to leverage AI in its content creation process.

What part one of this series covered

In part one of this two-part blog series, we acknowledged some of the challenges, including complexities with migration, consistency, version control and ownership, and a need for human oversight as the reasons why the life sciences just aren’t ready to use AI without the control of a structured content management solution.

Why can’t I just use AI on its own, part 2

Today, we’re sharing five more reasons. Let’s jump right in:

1. When exporting or submitting content, accuracy matters

Creating quality documentation is just the start. It must be delivered correctly. Whether it’s specific formats where the documents must meet regulatory standards or a submission process that must be error-free and timely, AI tools should support exporting in various formats and facilitate the submission process. A structured content management solution can help ensure accuracy.

2. Reporting requires essential insights

In the drug development process, regular reporting is a requirement — effective reporting keeps everyone informed and supports addressing potential issues early. On its own, AI cannot provide the essential insights into document creation, review, and approval that detailed reports require. A structured component management solution, combined with AI, can leverage metrics to help identify discrepancies or compliance issues.

3. Different users, different access levels

In regulated industries, controlling who can access and modify documents is essential. How is AI able to understand different permission and access levels? With a structured content solution, you can enable role-based access so different types of users (and individuals) can have different permissions. This extra security can help prevent unauthorized modifications. The right solutions protect sensitive information and maintain documentation integrity. Can your AI do that on its own?

4. Navigating existing IT systems is no walk in the park

AI systems need to integrate well with existing IT systems…but this is easier said than done. Effective integration enhances overall efficiency and accuracy in documentation, but this requires a solution that is designed to work with old/existing document management systems and regulatory portals. Don’t forget: your data flow needs smooth and accurate exchange between systems.

5. Just how reliable is the AI you are using?

Before AI can be used in regulated environments, it must be validated. A structured content management solution that utilizes AI provides the necessary framework to

• Perform validation testing to ensure accuracy, reliability, and compliance.
• Provide proof of compliance and performance of documentation.

Proper validation through a structured content management solution can help minimize risks and ensure that AI usage meets all regulatory requirements.

Choose Docuvera to be your bridge to the content future

AI offers great promise for the pharmaceutical industry, so long as it’s used in conjunction with tools that both provide checks and balances and ensure the human element is highly integrated into the documentation process. Docuvera’s structured content management solution that leverages AI offers the best of both worlds.

To learn more about how we’re approaching AI, download our whitepaper, AI + Structured Content: A new era of pharmaceutical documentation.